Director of Exercise Science selected for subcommittee developed to help address health and fitness technology standards
Raleigh, NC – April 14, 2015 – Valencell, a leader in performance biometric data sensor technology, today announced that Chris Eschbach, Ph.D., its Director of Exercise Science and Clinical Trials, has joined the Consumer Electronics Association’s (CEA)® new Health and Fitness Technology Subcommittee. The committee will develop standards and recommended practices for consumer health and fitness technology.
“Today’s wearable products are feeding consumers data that oftentimes does not deliver a personalized, accurate picture of the user’s health and wellness. This committee is a great first step in changing this,” said Chris Eschbach, Ph.D., Valencell’s Director of Exercise Science and Clinical Trials. “CEA does an excellent job in identifying new trends, and areas for improvement, as well as establishing industry standards for excellence. I am excited to play a part in this critical group and look forward to collaborating with fellow industry experts to establish technology standards in health and wellness.”
Eschbach also serves on the board of the CEA’s Health and Fitness Technology Division, developed to provide CEA members with educational, public engagement and networking opportunities. The Division also conducts market research and educates consumers about health and fitness technology products, apps and services.
As the Director of Exercise and Clinical Trials at Valencell, Eschbach coordinates internal and external clinical trials, supervises and executes validation testing in the lab and field, and contributes to the research and development of new technology related to physiological biometrics as applied to exercise, medical and military situations. Valencell’s licensing partners work closely with Eschbach and his team to validate the biometric sensor accuracy and reliability and to test their product in the state-of-the-art performance lab, located in Valencell’s Raleigh headquarters.
Founded in 2006 and headquartered in Raleigh, North Carolina, Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands, first responder/military markets, consumer healthcare brands, and gaming companies for integration into their products. Valencell’s PerformTek sensor technology powers the most accurate wearable biometric sensors that continuously measure heart rate and activity. Valencell has invested years into research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.